Explore how urinary N-acetyl-beta-D-glucosaminidase (NAG) serves as an early warning system for chemotherapy-induced kidney damage in cisplatin-treated patients.
Discover how a groundbreaking serum proteomics approach is revolutionizing prostate cancer diagnosis, moving beyond PSA tests to precise multi-protein signatures.
Discover how KLK4, a kallikrein-related peptidase, is transforming breast cancer diagnosis through its unique molecular signature and association with tumor aggression.
Exploring the unexpected role of prostate-specific antigen (PSA) as a potential diagnostic marker for breast cancer in women.